<div id="readability-page-1"><p>FUKOKU MUTUAL LIFE INSURANCE Co trimmed its position in  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 21.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,334 shares of the healthcare conglomerate's stock after selling 931 shares during the quarter. FUKOKU MUTUAL LIFE INSURANCE Co's holdings in UnitedHealth Group were worth $1,040,000 as of its most recent filing with the Securities and Exchange Commission.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy</li></ul><p>A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. LFA Lugano Financial Advisors SA bought a new position in shares of  UnitedHealth Group in the second quarter worth about $25,000.  Bayforest Capital Ltd increased its position in  UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the period.  Islay Capital Management LLC acquired a new position in shares of  UnitedHealth Group during the second quarter worth approximately $31,000.  Clal Insurance Enterprises Holdings Ltd grew its stake in shares of  UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the last quarter.  Finally, Glass Jacobson Investment Advisors llc raised its stake in  UnitedHealth Group by 80.9% during the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate's stock valued at $38,000 after purchasing an additional 55 shares during the last quarter. Institutional investors and hedge funds own  87.86% of the company's stock. </p><h2>UnitedHealth Group Stock Performance</h2><p>UnitedHealth Group stock opened at $309.19 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The stock has a fifty day moving average price of $346.20 and a two-hundred day moving average price of $317.57. The firm has a market capitalization of $280.08 billion, a P/E ratio of 16.14, a P/E/G ratio of 2.28 and a beta of 0.47. </p><ul><li>UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down</li></ul><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the prior year, the firm earned $7.15 EPS. The firm's quarterly revenue was up 12.2% compared to the same quarter last year.  As a group, analysts anticipate that  UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year. </p><h2>UnitedHealth Group Announces Dividend</h2><p>The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date is Monday, December 8th. UnitedHealth Group's dividend payout ratio (DPR) is presently 46.14%. </p><h2>Analyst Ratings Changes</h2><ul><li>Big Banks Are Setting the Tone as Earnings Season Kicks Off</li></ul><p>Several research analysts have recently issued reports on UNH shares. Leerink Partners  set a $410.00 price objective on shares of UnitedHealth Group and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, October 29th. Mizuho boosted their price target on UnitedHealth Group from $300.00 to $430.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, October 9th. Wells Fargo &amp; Company lifted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an &#34;overweight&#34; rating in a report on Tuesday, October 7th. Bank of America upped their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a &#34;neutral&#34; rating in a research note on Wednesday, October 8th. Finally, Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an &#34;outperform&#34; rating on the stock in a report on Wednesday, July 30th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have assigned  a Hold rating and three have issued  a Sell rating to the company's stock. According to MarketBeat, the stock  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $397.12.</p><p><b>Get Our Latest Stock Analysis on UnitedHealth Group</b></p><h2>About UnitedHealth Group</h2> (Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Compound Interest and Why It Matters When Investing</li><li>Is Tesla Setting Up for a Year-End Rebound—or a Collapse?</li><li>What is a Secondary Public Offering? What Investors Need to Know</li><li>Applied Materials: Up 40% in 2025 With Room to Run Long-Term</li><li>3 Grocery Stocks That Are Proving They Are Still Essential </li><li>onsemi Places a $6 Billion Bet on Its Own Stock</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>FUKOKU MUTUAL LIFE INSURANCE Co reduced its stake in UnitedHealth Group by 21.8% in Q2, selling 931 shares, now holding 3,334 shares valued at $1,040,000. Institutional investors own 87.86% of UnitedHealth. The stock opened at $309.19, with a 52-week range of $234.60-$622.83. UnitedHealth reported Q3 earnings of $2.92 per share, exceeding estimates, with revenue up 12.2% year-over-year. A quarterly dividend of $2.21 per share is announced, payable on December 16th. Analysts have mixed ratings, with price targets ranging from $325 to $430.</p>

FUKOKU MUTUAL LIFE INSURANCE Co Sells 931 Shares of UnitedHealth Group Incorporated $UNH